Monday, February 23, 2015 11:55:07 PM
With animal studies complete--safe and efficacious-- Propanc will have the leverage to negotiate financing human trials. With the cancer marketplace encompassing massive $$$, that would be enough for any financier to put up the $$ to finance human trials and Propanc would have the negotiating power to achieve the terms of agreement they want.
The abstract potential of Propanc is becoming more and more concrete. PPS will gradually increase, and the authorized shares as well; the two are not mutually exclusive with time.
Here we go.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM